While 2025's IPO boom is likely being enjoyed by Wall Street’s investment bankers, it may be even better news for private ...

Medical supply giant Medline's shares rose 41% above their offer price in their hotly anticipated New York debut on Wednesday, rounding out a strong year for U.S. IPOs with volumes hitting their ...

First-time share sales in the U.S. this year have raised a combined $46.15 billion — excluding blank-check firms — the ...

Jim Boyle, Medline CEO, celebrates with others as medical supplies giant Medline (MDLN) holds it's IPO at Nasdaq stock market ...

Medline shares rose 20.7% in their hotly anticipated New York debut today, valuing the medical supply giant at $46 billion in the largest U.S. initial public offering since Rivian’s 2021 listing, ...

Medline will debut on the Nasdaq later on Wednesday after the U.S. medical supply giant raised $6.26 billion in the biggest ...

Hashkey Holdings shares slid 3% on debut after raising $206 million via an Initial public offering in Hong Kong.

Despite a U.S. government shutdown that hit the "pause" button on new initial public offerings, the IPO market is expected to finish 2025 as it started, with a flurry of newly minted publicly ...

Medline’s bigger product lineup and strong cash flow gives it a leg up on competitors, according to Jonathan Palmer, a Bloomberg Intelligence health-care analyst, creating a virtuous circle that ...

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's ...